|
|
||||||||
Department of Medicine, University of New South Wales, Liverpool Hospital, Liverpool, New South Wales, Australia
Anti-CD4 mAb-induced tolerance to transplanted tissues has been
proposed as due to down-regulation of Th1 cells by preferential
induction of Th2 cytokines, especially IL-4. This study examined the
role of CD4+ cells and cytokines in tolerance to fully
allogeneic PVG strain heterotopic cardiac allografts induced in
naive DA rats by treatment with MRC Ox38, a nondepleting anti-CD4
mAb. All grafts survived >100 days but had a minor mononuclear cell
infiltrate that increased mRNA for the Th1 cytokines IL-2, IFN-
, and
TNF-ß, but not for Th2 cytokines IL-4 and IL-6 or the cytolytic
molecules perforin and granzyme A. These hosts accepted PVG skin grafts
but rejected third-party grafts, which were not blocked by
anti-IL-4 mAb. Cells from these tolerant hosts proliferated in MLC
and produced IL-2, IFN-
, and IL-4 at levels equivalent to naive
cells. Unfractionated and CD4+ T cells, but not
CD8+ T cells, transferred specific tolerance to irradiated
heart grafted hosts and inhibited reconstitution of rejection by
cotransferred naive cells. This transfer of tolerance was associated
with normal induction of IL-2 and delayed induction of IFN-
, but not
with increased IL-4 or IL-10 mRNA. Transfer of tolerance was also not
inhibited by anti-IL-4 mAb. This study demonstrated that tolerance
induced by a nondepleting anti-CD4 mAb is maintained by a
CD4+ suppressor T cell that is not associated with
preferential induction of Th2 cytokines or the need for IL-4; nor is it
associated with an inability to induce Th1 cytokines or
anergy.
This article has been cited by other articles:
![]() |
C. F. Jessup, H. M. Brereton, P. J. Sykes, M. A. Thiel, D. J. Coster, and K. A. Williams Local Gene Transfer to Modulate Rat Corneal Allograft Rejection Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1675 - 1681. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Godfrey, D. J. Spoden, Y. G. Ge, S. R. Baker, B. Liu, B. L. Levine, C. H. June, B. R. Blazar, and S. B. Porter Cord blood CD4+CD25+-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function Blood, January 15, 2005; 105(2): 750 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Godfrey, Y. G. Ge, D. J. Spoden, B. L. Levine, C. H. June, B. R. Blazar, and S. B. Porter In vitro-expanded human CD4+CD25+ T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures Blood, July 15, 2004; 104(2): 453 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Gray, P. Arosio, and P. Hersey Association of Increased Levels of Heavy-Chain Ferritin with Increased CD4+ CD25+ Regulatory T-Cell Levels in Patients with Melanoma Clin. Cancer Res., July 1, 2003; 9(7): 2551 - 2559. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen, M. S. Ford, K. J. Young, M. I. Cybulsky, and L. Zhang Role of Double-Negative Regulatory T Cells in Long-Term Cardiac Xenograft Survival J. Immunol., February 15, 2003; 170(4): 1846 - 1853. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Laub, R. Brecht, M. Dorsch, U. Valey, K. Wenk, and F. Emmrich Anti-Human CD4 Induces Peripheral Tolerance in a Human CD4+, Murine CD4-, HLA-DR+ Advanced Transgenic Mouse Model J. Immunol., September 15, 2002; 169(6): 2947 - 2955. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Chiffoleau, G. Beriou, P. Dutartre, C. Usal, J.-P. Soulillou, and M. C. Cuturi Role for Thymic and Splenic Regulatory CD4+ T Cells Induced by Donor Dendritic Cells in Allograft Tolerance by LF15-0195 Treatment J. Immunol., May 15, 2002; 168(10): 5058 - 5069. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Gray, P. Arosio, and P. Hersey Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells Blood, May 1, 2002; 99(9): 3326 - 3334. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Spicer, H. Ha, R. A. Boyd, X. Y. He, N. Carter, G. Tran, M. J. Penny, S. J. Hodgkinson, and B. M. Hall IL-4 Therapy Prevents the Development of Proteinuria in Active Heymann Nephritis by Inhibition of Tc1 Cells J. Immunol., October 1, 2001; 167(7): 3725 - 3733. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. T. Tran, N. Carter, X. Y. He, T. S. Spicer, K. M. Plain, M. Nicolls, B. M. Hall, and S. J. Hodgkinson Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on Th1 cells that is augmented by IL-4 Int. Immunol., September 1, 2001; 13(9): 1109 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hara, C. I. Kingsley, M. Niimi, S. Read, S. E. Turvey, A. R. Bushell, P. J. Morris, F. Powrie, and K. J. Wood IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo J. Immunol., March 15, 2001; 166(6): 3789 - 3796. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Nicolls, M. Coulombe, H. Yang, A. Bolwerk, and R. G. Gill Anti-LFA-1 Therapy Induces Long-Term Islet Allograft Acceptance in the Absence of IFN-{gamma} or IL-4 J. Immunol., April 1, 2000; 164(7): 3627 - 3634. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |